American Century Companies Inc Novavax Inc Transaction History

American Century Companies Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$69.73 - $142.9 $260,790 - $534,446	-3,740 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$134.56 - $217.97 $843,018 - $1.37 Million	-6,265 Reduced 62.62%	3,740 $535,000
Q3 2021 Nov 10, 2021	BUY	$177.8 - $270.58 $839,038 - $1.28 Million	4,719 Added 89.27%	10,005 $2.07 Million
Q2 2021 Aug 05, 2021	SELL	$121.0 - $257.67 $3.85 Million - $8.2 Million	-31,812 Reduced 85.75%	5,286 $1.12 Million
Q1 2021 May 14, 2021	BUY	$112.98 - $319.93 $3.63 Million - $10.3 Million	32,131 Added 646.89%	37,098 $6.73 Million
Q3 2020 Nov 13, 2020	BUY	$79.44 - $178.51 $394,578 - $886,659	4,967 New	4,967 $538,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.